| Field | Row 1 |
|---|---|
| adsh | 0001213900-25-041566 |
| cik | 2019505 |
| name | HEALTH IN TECH, INC. |
| sic | 6411 |
| countryba | US |
| stprba | FL |
| cityba | STUART |
| zipba | 34994 |
| bas1 | 701 S. COLORADO AVE |
| bas2 | SUITE 1 |
| baph | 888-373-0333 |
| countryma | US |
| stprma | FL |
| cityma | STUART |
| zipma | 34994 |
| mas1 | 701 S. COLORADO AVE |
| mas2 | SUITE 1 |
| countryinc | |
| stprinc | |
| ein | 000000000 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250509 |
| accepted | 2025-05-09 16:39:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ea0241104-10q_health_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-041566 | 20240331 | Accrued Development Of Software Included In Accounts Payable And Accrued Expenses | 9500.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20240331 | Revenues | 5124931.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Accrued Income Taxes Current | 205253.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Assets | 21330200.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Cash And Cash Equivalents At Carrying Value | 7849248.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1359534.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 7575037.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Common Stock Shares Issued | 11700000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Shares Outstanding | 42973204.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20250331 | Deferred Offering Costs | 91500.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Earnings Per Share Diluted | 0.0100 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Interest Paid Net | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20241231 | Liabilities | 2599461.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Net Cash Provided By Used In Operating Activities | -680212.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Net Income Loss | 100536.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-041566 | 20240331 | Nonoperating Income Expense | -140688.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Nonoperating Income Expense | 203765.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Operating Expenses | 4874741.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Operating Lease Liability Noncurrent | 139811.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Other Liabilities Current | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20241231 | Other Receivables Net Current | 500252.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Payments Of Deferred Offering Costs | 243210.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20250331 | Retained Earnings Accumulated Deficit | 4439988.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Revenues | 3340296.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Revenues From Fees; | ||
| 0001213900-25-041566 | 20250331 | Shares Outstanding | 42973204.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20231231 | Stockholders Equity | 22500.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 51769358.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Prepaid Expense And Other Assets Current | 787161.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Accrued Deferred Offering Costs Included In Accounts Payable And Accrued Expenses | 110044.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2416350.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20241231 | Common Stock Shares Outstanding | 11700000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20241231 | Common Stock Value | 11700.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -1485329.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Increase Decrease In Accrued Income Taxes Payable | 220303.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Investment Income Interest | 85366.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Liabilities And Stockholders Equity | 15768489.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Net Cash Provided By Used In Investing Activities | -703475.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | |||
| 0001213900-25-041566 | 20250331 | Operating Lease Liability Noncurrent | 121595.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Operating Lease Right Of Use Asset | 190275.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Other Receivables Net Current | 3989788.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Revenues | 807374.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Revenues From Fees; Service Revenue= H I Card; | ||
| 0001213900-25-041566 | 20240331 | Shares Outstanding | 29269358.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20250331 | Shares Outstanding | 11700000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20241231 | Stockholders Equity | 42915.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20250331 | Stockholders Equity | 42973.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 54619858.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Net Cash Provided By Used In Investing Activities | -133394.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Accrued Deferred Offering Costs Included In Accounts Payable And Accrued Expenses | 33250.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20250331 | Amortization Of Debt Discount Premium | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Assets Noncurrent | 5758362.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Capitalized Computer Software Net | 3962461.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -1056816.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Assets Current | 15571838.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240531 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20241231 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Value | 42973.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20240331 | Deferred Income Tax Expense Benefit | -60070.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Deferred Income Tax Expense Benefit | -34473.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 191734.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 684423.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Income Taxes Paid Net | 39235.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Income Tax Expense Benefit | 91198.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Increase Decrease In Accrued Income Taxes Payable | 112032.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Interest Income Other | 15999.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Investment Income Interest | 24312.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Liabilities Current | 2130974.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Liabilities Noncurrent | 415798.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Net Cash Provided By Used In Operating Activities | 527353.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Notes And Loans Receivable Net Noncurrent | 831994.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Operating Expenses | 3802598.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Other Liabilities Current | 780045.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Provision For Refund Liability | 780045.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20240331 | Revenues | 2532922.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Revenues From Fees; Service Revenue= S M R; | ||
| 0001213900-25-041566 | 20231231 | Shares Outstanding | 29269358.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20231231 | Stockholders Equity | 6093226.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Stockholders Equity | 22500.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20240331 | Stockholders Equity | 2770538.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | Shares, common stock amount and additional paid-in capital data are presented on a retroactive basis to reflect the effects of the stock split at a 1.5-for-1 ratio effected on June 4, 2024. | |
| 0001213900-25-041566 | 20240331 | Stockholders Equity | 3371455.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-041566 | 20241231 | Stockholders Equity | 11700.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20241231 | Stockholders Equity | 9173017.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-041566 | 20250331 | Stock Issued During Period Value Share Based Compensation | 493113.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Shares Issued | 42973204.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20241231 | Common Stock Shares Outstanding | 42914870.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Shares Outstanding | 11700000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20241231 | Common Stock Value | 42915.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Value | 11700.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20241231 | Deferred Offering Costs | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Depreciation Depletion And Amortization | 135983.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Increase Decrease In Accounts Receivable | -221102.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 89988.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Liabilities Current | 6753611.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Liabilities Noncurrent | 468487.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-041566 | 20240331 | Other Nonoperating Income | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Other Nonoperating Income | 118399.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Research And Development Expense | 760196.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Retained Earnings Accumulated Deficit | 3941396.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Revenues | 1784635.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Revenues From Underwriting Modeling I C E; | ||
| 0001213900-25-041566 | 20250331 | Revenues | 5663000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Revenues From Fees; Service Revenue= S M R; | ||
| 0001213900-25-041566 | 20240331 | Share Based Compensation | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Share Based Compensation | 493171.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20231231 | Shares Outstanding | 22500000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20241231 | Shares Outstanding | 42914870.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20231231 | Stockholders Equity | 2770538.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-041566 | 20241231 | Stockholders Equity | 13169028.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Accounts Payable And Accrued Liabilities Current | 5478888.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Additional Paid In Capital Common Stock | 9173017.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Amortization Of Debt Discount Premium | 165000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Capitalized Computer Software Net | 4736093.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 7849248.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20241231 | Common Stock Shares Issued | 42914870.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Shares Issued | 11700000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20240331 | Cost Of Revenue | 989911.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Depreciation Depletion And Amortization | 134787.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Earnings Per Share Basic | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Income Tax Expense Benefit | 185831.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Interest Expense Nonoperating | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Liabilities And Stockholders Equity | 21330200.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Net Cash Provided By Used In Financing Activities | -98089.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | |||
| 0001213900-25-041566 | 20240331 | Net Income Loss | 100536.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-041566 | 20250331 | Net Income Loss | 498592.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Operating Lease Liability Current | 66881.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Payments To Develop Software | 133394.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Revenues | 5663000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Revenues From Fees; | ||
| 0001213900-25-041566 | 20250331 | Revenues | 2351984.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Revenues From Underwriting Modeling I C E; | ||
| 0001213900-25-041566 | 20231231 | Stockholders Equity | 29269.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20231231 | Stockholders Equity | 3270919.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-041566 | 20240331 | Stockholders Equity | 29269.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20250331 | Stockholders Equity | 9666130.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-041566 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 58334.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20250331 | Stock Issued During Period Value Share Based Compensation | 493171.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Stock Issued During Period Value Share Based Compensation | 58.0000 | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20241231 | Accounts Receivable Net Current | 1647103.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Accrued Development Of Software Included In Accounts Payable And Accrued Expenses | 256140.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20241231 | Assets Noncurrent | 4984725.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Cash And Cash Equivalents At Carrying Value | 7575037.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Cost Of Revenue | 2659585.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Earnings Per Share Basic | 0.0100 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | General And Administrative Expense | 1999194.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Gross Profit | 5355399.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Increase Decrease In Other Receivables | 3489536.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-041566 | 20250331 | Payments Of Deferred Offering Costs | 98089.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20250331 | Revenues | 8014984.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Revenues | USD | 1 | us-gaap/2025 | Product Or Service= Revenues From Fees; Service Revenue= H I Card; | |||
| 0001213900-25-041566 | 20240331 | Shares Outstanding | 22500000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20241231 | Shares Outstanding | 11700000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20240331 | Stockholders Equity | 6193762.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Stockholders Equity | 3941396.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-041566 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-041566 | 20241231 | Accounts Payable And Accrued Liabilities Current | 1858840.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Accrued Income Taxes Current | 425556.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Additional Paid In Capital Common Stock | 9666130.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Assets | 15768489.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-041566 | 20241231 | Common Stock Shares Issued | 545512.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Subsidiary Sale Of Stock= I P O; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Shares Issued | 20334.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20240331 | Earnings Per Share Diluted | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 3420497.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Increase Decrease In Operating Lease Rightofuse Assets And Liabilities Net | -624.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20250331 | Increase Decrease In Operating Lease Rightofuse Assets And Liabilities Net | -19.0000 | USD | 1 | 0001213900-25-041566 | |||
| 0001213900-25-041566 | 20240331 | Increase Decrease In Other Receivables | -237093.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Liabilities | 7169409.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Net Cash Provided By Used In Financing Activities | -243210.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-041566 | 20250331 | Net Income Loss | 498592.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-041566 | 20250331 | Payments To Develop Software | 703475.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Research And Development Expense | 537721.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Selling And Marketing Expense | 1043208.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Stockholders Equity | 14160791.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Stockholders Equity | 11700.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-041566 | 20250331 | Accounts Receivable Net Current | 2110601.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Assets Current | 10783764.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -274211.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240531 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Plan Name= Two Thousand Twenty Two Equity Incentive Plan; | ||
| 0001213900-25-041566 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-041566 | 20241231 | Deferred Income Tax Liabilities Net | 328676.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Deferred Income Tax Liabilities Net | 294203.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | General And Administrative Expense | 3246765.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Gross Profit | 4135020.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Income Taxes Paid Net | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20250331 | Increase Decrease In Accounts Receivable | 463498.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 1017751.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Interest Expense Nonoperating | 165000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Interest Income Other | 15999.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Interest Paid Net | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-041566 | 20241231 | Notes And Loans Receivable Net Noncurrent | 815995.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Operating Lease Liability Current | 69122.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20241231 | Operating Lease Right Of Use Asset | 206269.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Prepaid Expense And Other Assets Current | 1804912.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20240331 | Provision For Refund Liability | USD | 1 | 0001213900-25-041566 | ||||
| 0001213900-25-041566 | 20250331 | Selling And Marketing Expense | 1090255.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Stockholders Equity | 4439988.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-041566 | 20250331 | Stock Issued During Period Shares Share Based Compensation | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | |||
| 0001213900-25-041566 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | |||
| 0001213900-25-041566 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 51769358.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-041566 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 56996936.0000 | shares | 1 | us-gaap/2025 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Other Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Investment Income Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Increase Decrease In Operating Lease Rightofuse Assets And Liabilities Net | 0001213900-25-041566 | 1 | 0 | monetary | D | C | Increase Decrease In Operating Lease Rightofuse Assets And Liabilities Net | Represents the mount of increase (decrease) in operating lease right-of-use assets and liabilities, net. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation | Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Amortization Of Debt Discount Premium | us-gaap/2025 | 0 | 0 | monetary | D | D | Amortization of Debt Discount (Premium) | Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. |
| Capitalized Computer Software Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Capitalized Computer Software, Net | The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Interest Income Other | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Income, Other | Amount of interest income earned from interest bearing assets classified as other. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Accrued Deferred Offering Costs Included In Accounts Payable And Accrued Expenses | 0001213900-25-041566 | 1 | 0 | monetary | D | C | Accrued Deferred Offering Costs Included In Accounts Payable And Accrued Expenses | Represent the amount of accrued deferred offering costs included in accounts payable and accrued expenses. |
| Payments Of Deferred Offering Costs | 0001213900-25-041566 | 1 | 0 | monetary | D | C | Payments Of Deferred Offering Costs | Represents the cash outflow of deferred offering costs. |
| Depreciation Depletion And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Accrued Income Taxes Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Income Taxes, Current | Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations. |
| Deferred Income Tax Liabilities Net | us-gaap/2025 | 0 | 0 | monetary | I | C | Deferred Income Tax Liabilities, Net | Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting. |
| Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Increase Decrease In Accrued Income Taxes Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable | The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
| Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Receivables Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Receivables, Net, Current | Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. |
| Selling And Marketing Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
| Deferred Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Accrued Development Of Software Included In Accounts Payable And Accrued Expenses | 0001213900-25-041566 | 1 | 0 | monetary | D | C | Accrued Development Of Software Included In Accounts Payable And Accrued Expenses | Represent the amount of accrued development of software included in accounts payable and accrued expenses. |
| Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Increase Decrease In Other Receivables | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Receivables | Amount of increase (decrease) in receivables classified as other. |
| Interest Expense Nonoperating | us-gaap/2025 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2025 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Provision For Refund Liability | 0001213900-25-041566 | 1 | 0 | monetary | D | D | Provision For Refund Liability | Represents the value of provision for refund liability. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Deferred Offering Costs | us-gaap/2025 | 0 | 0 | monetary | I | D | Deferred Offering Costs | Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. |
| Interest Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activity | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Additional Paid In Capital Common Stock | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Payments To Develop Software | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Develop Software | The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization. |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Income Taxes Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Notes And Loans Receivable Net Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Financing Receivable, after Allowance for Credit Loss, Noncurrent | Amount, after allowance for credit loss, of financing receivable, classified as noncurrent. |
| Other Nonoperating Income | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Nonoperating Income | Amount of income related to nonoperating activities, classified as other. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-041566 | 2 | 8 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001213900-25-041566 | 2 | 9 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Accounts receivable, net | 0 |
| 0001213900-25-041566 | 2 | 10 | BS | 0 | H | Other Receivables Net Current | us-gaap/2025 | Other receivables | 0 |
| 0001213900-25-041566 | 2 | 11 | BS | 0 | H | Deferred Offering Costs | us-gaap/2025 | Deferred offering costs | 0 |
| 0001213900-25-041566 | 2 | 12 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001213900-25-041566 | 2 | 13 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001213900-25-041566 | 2 | 15 | BS | 0 | H | Capitalized Computer Software Net | us-gaap/2025 | Software | 0 |
| 0001213900-25-041566 | 2 | 16 | BS | 0 | H | Notes And Loans Receivable Net Noncurrent | us-gaap/2025 | Loans receivable, net | 0 |
| 0001213900-25-041566 | 2 | 17 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating lease right of use assets | 0 |
| 0001213900-25-041566 | 2 | 18 | BS | 0 | H | Assets Noncurrent | us-gaap/2025 | Total non-current assets | 0 |
| 0001213900-25-041566 | 2 | 19 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001213900-25-041566 | 2 | 21 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2025 | Accounts payable and accrued expenses | 0 |
| 0001213900-25-041566 | 2 | 22 | BS | 0 | H | Accrued Income Taxes Current | us-gaap/2025 | Income taxes payable | 0 |
| 0001213900-25-041566 | 2 | 23 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Operating lease liabilities current | 0 |
| 0001213900-25-041566 | 2 | 24 | BS | 0 | H | Other Liabilities Current | us-gaap/2025 | Other current liabilities | 0 |
| 0001213900-25-041566 | 2 | 25 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001213900-25-041566 | 2 | 27 | BS | 0 | H | Deferred Income Tax Liabilities Net | us-gaap/2025 | Deferred tax liabilities | 0 |
| 0001213900-25-041566 | 2 | 28 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Operating lease liabilities non-current | 0 |
| 0001213900-25-041566 | 2 | 29 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2025 | Total non-current liabilities | 0 |
| 0001213900-25-041566 | 2 | 30 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001213900-25-041566 | 2 | 31 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and contingencies (Note 5) | 0 |
| 0001213900-25-041566 | 2 | 33 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, value | 0 |
| 0001213900-25-041566 | 2 | 34 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-041566 | 2 | 35 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Retained earnings | 0 |
| 0001213900-25-041566 | 2 | 36 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
| 0001213900-25-041566 | 2 | 37 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders equity | 0 |
| 0001213900-25-041566 | 3 | 6 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-041566 | 3 | 7 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized | 0 |
| 0001213900-25-041566 | 3 | 8 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued | 0 |
| 0001213900-25-041566 | 3 | 9 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, Shares outstanding | 0 |
| 0001213900-25-041566 | 4 | 12 | IS | 0 | H | Revenues | us-gaap/2025 | Total revenues | 0 |
| 0001213900-25-041566 | 4 | 13 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | Cost of revenues | 0 |
| 0001213900-25-041566 | 4 | 14 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross profit | 0 |
| 0001213900-25-041566 | 4 | 16 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2025 | Sales and marketing expenses | 0 |
| 0001213900-25-041566 | 4 | 17 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative expenses | 0 |
| 0001213900-25-041566 | 4 | 18 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development expenses | 0 |
| 0001213900-25-041566 | 4 | 19 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001213900-25-041566 | 4 | 21 | IS | 0 | H | Investment Income Interest | us-gaap/2025 | Interest income | 0 |
| 0001213900-25-041566 | 4 | 22 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2025 | Interest expenses | 1 |
| 0001213900-25-041566 | 4 | 23 | IS | 0 | H | Other Nonoperating Income | us-gaap/2025 | Other income | 0 |
| 0001213900-25-041566 | 4 | 24 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total other income (expense), net | 0 |
| 0001213900-25-041566 | 4 | 25 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Income before income tax expense | 0 |
| 0001213900-25-041566 | 4 | 26 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income taxes | 1 |
| 0001213900-25-041566 | 4 | 27 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001213900-25-041566 | 4 | 29 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic (in Dollars per share) | 0 |
| 0001213900-25-041566 | 4 | 30 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Diluted (in Dollars per share) | 0 |
| 0001213900-25-041566 | 4 | 32 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Basic (in Shares) | 0 |
| 0001213900-25-041566 | 4 | 33 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Diluted (in Shares) | 0 |
| 0001213900-25-041566 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-041566 | 5 | 13 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-041566 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2025 | Stock-based compensation | 0 |
| 0001213900-25-041566 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2025 | Stock-based compensation (in Shares) | 0 |
| 0001213900-25-041566 | 5 | 16 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001213900-25-041566 | 5 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-041566 | 5 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-041566 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001213900-25-041566 | 6 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2025 | Amortization expense | 0 |
| 0001213900-25-041566 | 6 | 5 | CF | 0 | H | Provision For Refund Liability | 0001213900-25-041566 | Provision for refund liability | 0 |
| 0001213900-25-041566 | 6 | 6 | CF | 0 | H | Deferred Income Tax Expense Benefit | us-gaap/2025 | Deferred tax benefits | 0 |
| 0001213900-25-041566 | 6 | 7 | CF | 0 | H | Amortization Of Debt Discount Premium | us-gaap/2025 | Amortization of debt discount | 0 |
| 0001213900-25-041566 | 6 | 8 | CF | 0 | H | Interest Income Other | us-gaap/2025 | Interest income | 1 |
| 0001213900-25-041566 | 6 | 9 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation expense | 0 |
| 0001213900-25-041566 | 6 | 11 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Accounts receivable | 1 |
| 0001213900-25-041566 | 6 | 12 | CF | 0 | H | Increase Decrease In Other Receivables | us-gaap/2025 | Other receivables | 1 |
| 0001213900-25-041566 | 6 | 13 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other current assets | 1 |
| 0001213900-25-041566 | 6 | 14 | CF | 0 | H | Increase Decrease In Operating Lease Rightofuse Assets And Liabilities Net | 0001213900-25-041566 | Operating lease right-of-use assets and liabilities, net | 1 |
| 0001213900-25-041566 | 6 | 15 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | Accounts payable and accrued expenses | 0 |
| 0001213900-25-041566 | 6 | 16 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2025 | Income taxes payable | 0 |
| 0001213900-25-041566 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash provided by (used in) operating activities | 0 |
| 0001213900-25-041566 | 6 | 19 | CF | 0 | H | Payments To Develop Software | us-gaap/2025 | Development of software | 1 |
| 0001213900-25-041566 | 6 | 20 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash used in investing activities | 0 |
| 0001213900-25-041566 | 6 | 22 | CF | 0 | H | Payments Of Deferred Offering Costs | 0001213900-25-041566 | Payments of deferred offering costs | 1 |
| 0001213900-25-041566 | 6 | 23 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash used in financing activities | 0 |
| 0001213900-25-041566 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | Decrease in cash and cash equivalents | 0 |
| 0001213900-25-041566 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and cash equivalents, beginning of period | 0 |
| 0001213900-25-041566 | 6 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and cash equivalents, end of period | 0 |
| 0001213900-25-041566 | 6 | 28 | CF | 0 | H | Interest Paid Net | us-gaap/2025 | Cash paid for interest | 0 |
| 0001213900-25-041566 | 6 | 29 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2025 | Cash paid for income taxes | 0 |
| 0001213900-25-041566 | 6 | 31 | CF | 0 | H | Accrued Deferred Offering Costs Included In Accounts Payable And Accrued Expenses | 0001213900-25-041566 | Accrued deferred offering costs included in accounts payable and accrued expenses | 0 |
| 0001213900-25-041566 | 6 | 32 | CF | 0 | H | Accrued Development Of Software Included In Accounts Payable And Accrued Expenses | 0001213900-25-041566 | Accrued development of software included in accounts payable and accrued expenses | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |